Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 9 studies | 25% ± 8% | |
epithelial cell | 7 studies | 21% ± 3% | |
type II pneumocyte | 5 studies | 19% ± 4% | |
astrocyte | 5 studies | 31% ± 10% | |
cardiac muscle cell | 4 studies | 19% ± 5% | |
retinal rod cell | 4 studies | 25% ± 3% | |
glutamatergic neuron | 4 studies | 26% ± 5% | |
retinal pigment epithelial cell | 3 studies | 35% ± 13% | |
GABAergic neuron | 3 studies | 21% ± 3% | |
interneuron | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 10409.84 | 653 / 653 | 98% | 26.44 | 592 / 605 |
lung | 97% | 4198.76 | 563 / 578 | 97% | 14.70 | 1116 / 1155 |
stomach | 91% | 3286.61 | 327 / 359 | 96% | 20.41 | 275 / 286 |
intestine | 85% | 3824.46 | 817 / 966 | 96% | 21.76 | 507 / 527 |
pancreas | 84% | 1211.71 | 275 / 328 | 97% | 15.59 | 172 / 178 |
brain | 81% | 2249.44 | 2143 / 2642 | 99% | 24.11 | 698 / 705 |
skin | 79% | 1657.00 | 1431 / 1809 | 95% | 24.90 | 450 / 472 |
kidney | 100% | 4490.03 | 89 / 89 | 70% | 10.75 | 627 / 901 |
esophagus | 75% | 1329.85 | 1078 / 1445 | 94% | 18.24 | 172 / 183 |
bladder | 76% | 712.81 | 16 / 21 | 79% | 10.22 | 399 / 504 |
uterus | 73% | 814.97 | 124 / 170 | 81% | 10.06 | 372 / 459 |
breast | 67% | 840.83 | 306 / 459 | 86% | 11.46 | 959 / 1118 |
prostate | 64% | 660.39 | 157 / 245 | 88% | 8.47 | 442 / 502 |
adrenal gland | 97% | 1923.72 | 250 / 258 | 42% | 3.05 | 97 / 230 |
ovary | 87% | 1027.06 | 156 / 180 | 47% | 3.04 | 204 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 38.51 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.07 | 1 / 1 |
muscle | 100% | 7320.40 | 800 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4156.37 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 93% | 4450.93 | 799 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 6.95 | 38 / 45 |
peripheral blood | 78% | 6454.49 | 727 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 7.05 | 21 / 29 |
adipose | 60% | 666.05 | 723 / 1204 | 0% | 0 | 0 / 0 |
liver | 25% | 269.08 | 56 / 226 | 35% | 2.95 | 141 / 406 |
blood vessel | 58% | 630.71 | 778 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006007 | Biological process | glucose catabolic process |
GO_0006000 | Biological process | fructose metabolic process |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0006089 | Biological process | lactate metabolic process |
GO_0009749 | Biological process | response to glucose |
GO_0006096 | Biological process | glycolytic process |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0006003 | Biological process | fructose 2,6-bisphosphate metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0004331 | Molecular function | fructose-2,6-bisphosphate 2-phosphatase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003873 | Molecular function | 6-phosphofructo-2-kinase activity |
Gene name | PFKFB2 |
Protein name | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (EC 2.7.1.105) (EC 3.1.3.46) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
Synonyms | |
Description | FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate. . FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate. . |
Accessions | ENST00000464777.5 ENST00000618513.4 F6RAZ1 ENST00000367079.3 [O60825-2] F6XNB3 A0A087X2H4 B0FLL2 ENST00000411990.6 O60825 ENST00000545806.5 A0A087X278 ENST00000367080.8 [O60825-1] |